The global CRISPR market is experiencing rapid growth, driven by high demand for gene editing tools, particularly among academia and biotechnology companies. Key market drivers include advancements in drug discovery, synthetic genes, and healthcare R&D budgets, while challenges include ethical issues and limited awareness. North America currently holds the largest market share, but the Asia-Pacific region is anticipated to grow at the fastest rate due to emerging contract research organizations.